Zhuohao Liu
Overview
Explore the profile of Zhuohao Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen T, Liu J, Wang C, Wang Z, Zhou J, Lin J, et al.
J Immunother Cancer
. 2024 Aug;
12(8).
PMID: 39142719
Background: Oxylipin metabolism plays an essential role in glioma progression and immune modulation in the tumor microenvironment. Lipid metabolic reprogramming has been linked to macrophage remodeling, while the understanding of...
2.
Liu Y, Li Y, Liu Z, Feng T, Lin H, Li G, et al.
Molecules
. 2024 May;
29(9).
PMID: 38731479
Manganese molybdate has garnered considerable interest in supercapacitor research owing to its outstanding electrochemical properties and nanostructural stability but still suffers from the common problems of transition metal oxides not...
3.
Zhang K, Feng Y, Qiao X, Yu Y, Song Z, Liu Z, et al.
Chin Med J (Engl)
. 2023 Nov;
136(24):3008-3009.
PMID: 37974324
No abstract available.
4.
Liu P, Wang W, Fan J, Guo J, Wu T, Lu D, et al.
J Transl Med
. 2023 Jan;
21(1):40.
PMID: 36681849
Background: Current diagnosis tools for prostate cancer (PCa) such as serum PSA detection and prostate biopsy cannot distinguish dormant tumors from invasive malignancies, either be used as prognosis marker for...
5.
Liu Z, Zhou J, Yang X, Liu Y, Zou C, Lv W, et al.
Mol Cancer
. 2023 Jan;
22(1):3.
PMID: 36617554
Background: This study aimed to validate whether infusion of GD2-specific fourth-generation safety-designed chimeric antigen receptor (4SCAR)-T cells is safe and whether CAR-T cells exert anti-glioblastoma (GBM) activity. Methods: A total...
6.
Ge R, Wang C, Liu J, Jiang H, Jiang X, Liu Z
Mol Cancer Res
. 2022 Dec;
21(3):189-198.
PMID: 36469009
Implications: Our study highlights that targeting NFIX-GINS1 axis could be a novel and potential therapeutic approach for GBM treatment.
7.
Lin H, Wang L, Liu Z, Long K, Kong M, Ye D, et al.
Adv Sci (Weinh)
. 2022 May;
9(20):e2200742.
PMID: 35524581
Dysfunctional triglyceride-very low-density lipoprotein (TG-VLDL) metabolism is linked to metabolic-associated fatty liver disease (MAFLD); however, the underlying cause remains unclear. The study shows that hepatic E3 ubiquitin ligase murine double...
8.
Zhou J, Pei X, Yang Y, Wang Z, Gao W, Ye R, et al.
J Immunother Cancer
. 2021 Apr;
9(4).
PMID: 33858847
Background: High-grade gliomas are rapidly progressing tumors of the central nervous system, and are associated with poor prognosis and highly immunosuppressive microenvironments. Meanwhile, a better understanding of PD-L1, a major...
9.
Yang X, Liu J, Wang C, Cheng K, Xu H, Li Q, et al.
Oncogenesis
. 2021 Feb;
10(2):15.
PMID: 33579899
The development of glioblastoma (GBM) is typically accompanied by marked changes in lipid metabolism. Oxylipins and their catalyzed enzymes lipoxygenases (LOXs) have been shown to participate in the development of...
10.
Liu Z, Ge R, Zhou J, Yang X, Cheng K, Tao J, et al.
Oncogenesis
. 2020 Apr;
9(4):39.
PMID: 32291386
Enhanced migration is pivotal for the malignant development of glioblastoma (GBM), but the underlying molecular mechanism that modulates the migration of the GBM cells remains obscure. Here we show that...